©The Author(s) 2025.
World J Clin Oncol. Oct 24, 2025; 16(10): 110511
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.110511
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.110511
Table 4 Assessment of publication bias using funnel plot and Egger’s regression test
| Endpoint | No. of studies | Funnel plot | β1 (Egger) | SE | P value | Interpretation |
| MPR | 10 | Symmetrical | -2.36 | 1.47 | 0.109 | No evidence of small-study effects; the funnel plot does not suggest publication bias |
| ORR | 9 | Symmetrical (2 studies lie outside 95%CI limits) | -0.07 | 1.81 | 0.969 | No indication of small-study effects; the distribution is balanced across effect sizes |
| pCR | 10 | Asymmetrical; small studies cluster to the left | -5.00 | 1.59 | 0.0016 | Significant small-study effects; suggests potential publication bias favoring negative findings |
| Resection rate | 13 | Asymmetrical; small studies cluster to the right | +3.68 | 0.68 | < 0.0001 | Strong evidence of small-study effects; indicative of possible reporting bias or selective publication of favorable outcomes |
| Grade 3-4 TRAEs | 11 | Symmetrical | +0.11 | 0.79 | 0.887 | No evidence of small-study effects; results appear robust and not influenced by study size |
- Citation: Cicerone O, Oliviero B, Mantovani S, Maiocchi L, Ravetta V, Berton F, Corallo S, Vanoli A, Maestri M. Neoadjuvant immunotherapy in resectable hepatocellular carcinoma: A meta-analysis of the current evidence. World J Clin Oncol 2025; 16(10): 110511
- URL: https://www.wjgnet.com/2218-4333/full/v16/i10/110511.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i10.110511